Clavimox 625 Mg 12 Tablets

Clavimox 625 Mg 12 Tablets

Description:

Clavimox 625 mg 12 tablets (CLAVIMOX 625 MG 12 F.C.TABS.) is a prescription systemic antibiotic medicine from Pharco combining amoxicillin and clavulanic acid. It belongs to the beta-lactam/penicillin class and is used to treat a wide range of bacterial infections caused by beta-lactamase–producing organisms that are resistant to amoxicillin alone. Each film-coated tablet delivers broad-spectrum antibacterial activity for effective treatment of respiratory, ear, sinus, skin, and urinary tract infections in adults and adolescents as directed by a physician.

Indications:

• Lower respiratory tract infections, including bronchitis and pneumonia, caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
• Acute bacterial otitis media (middle ear infection) caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.
• Acute bacterial sinusitis caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.
• Skin and skin structure infections caused by beta-lactamase–producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species.
• Urinary tract infections (UTIs), including cystitis and complicated UTIs, caused by beta-lactamase–producing isolates of E. coli, Klebsiella species, and Enterobacter species.
• Other susceptible infections as determined by culture and sensitivity testing and at the discretion of the treating physician.

Active Ingredients / Key Components:

• Amoxicillin (as amoxicillin trihydrate) – 500 mg per film-coated tablet (exact salt form and concentration may vary by manufacturer presentation; detailed composition not provided in available data).
• Clavulanic acid (as potassium clavulanate) – 125 mg per film-coated tablet (exact salt form and concentration may vary by manufacturer presentation; detailed composition not provided in available data).
• Other inactive ingredients: film-coating agents, fillers, binders, and stabilizers (full excipient list and concentrations , please check the product leaflet or the manufacturer’s official website).

Dosage & Administration / How to Use:

• Clavimox 625 mg is for oral use only and should be taken exactly as prescribed by your doctor.
• Typical adult dose for many infections: 1 tablet (625 mg) every 8–12 hours, depending on the severity and site of infection. The exact dose, frequency, and duration must be determined by the physician.
• Take the tablets with a meal or snack to improve absorption and help reduce gastrointestinal side effects such as nausea and diarrhea.
• Swallow the film-coated tablet whole with a sufficient amount of water. Do not crush or chew unless your doctor or pharmacist advises otherwise.
• Duration of treatment usually ranges from 5 to 14 days, depending on the type and severity of infection. Always complete the full course even if symptoms improve early to prevent relapse and antibiotic resistance.
• If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed one.
• Use in children and patients with kidney or liver impairment requires dose adjustment and must be strictly guided by a healthcare professional.

Clinical Benefits:

• Provides broad-spectrum antibacterial coverage by combining amoxicillin with clavulanic acid to overcome beta-lactamase–mediated resistance.
• Effectively treats lower respiratory tract infections, sinusitis, and otitis media caused by resistant organisms, helping relieve symptoms such as cough, fever, and ear pain.
• Helps resolve skin and soft tissue infections, reducing redness, swelling, and pain associated with infected wounds or skin lesions.
• Treats urinary tract infections caused by beta-lactamase–producing bacteria, helping relieve symptoms such as burning urination, urgency, and frequency.
• Supports faster clinical recovery when used appropriately based on culture and sensitivity results and under medical supervision.

Warnings & Contraindications:

• Contraindicated in patients with a known hypersensitivity or allergy to amoxicillin, clavulanic acid, other penicillins, or any component of the formulation.
• Use with extreme caution in patients with a history of severe allergic reactions to beta-lactam antibiotics (penicillins, cephalosporins, carbapenems), including anaphylaxis, angioedema, or severe skin reactions.
• Use cautiously in patients with hepatic impairment or a history of liver dysfunction or jaundice associated with amoxicillin/clavulanate therapy.
• Dose adjustment may be required in patients with renal impairment; consult a physician for appropriate dosing.
• Prolonged or repeated use may result in overgrowth of non-susceptible organisms, including fungi; if superinfection occurs, appropriate measures should be taken.
• Antibiotic-associated colitis (including Clostridioides difficile–associated diarrhea) has been reported with nearly all antibacterial agents; if severe or persistent diarrhea occurs, discontinue the drug and seek medical advice immediately.
• Inform your doctor about all medications you are taking, especially anticoagulants (e.g., warfarin), methotrexate, allopurinol, or other antibiotics, due to potential interactions.
• Consult your doctor before use if pregnant or nursing. Amoxicillin/clavulanic acid should be used during pregnancy and breastfeeding only if clearly needed and under medical supervision.
• Not intended for viral infections such as common cold or influenza.
• Consult your doctor before use if you have liver disease, kidney disease, mononucleosis, gastrointestinal disease (especially colitis), or a history of severe drug allergies.
• Keep out of reach of children.

Side Effects:

• Common side effects: nausea, vomiting, diarrhea, abdominal pain, indigestion, headache, and mild skin rash.
• Less common side effects: dizziness, fatigue, oral or vaginal candidiasis (thrush), changes in taste, or mild elevation of liver enzymes.
• Serious side effects (seek immediate medical attention): severe allergic reactions such as rash, itching, swelling of face/lips/tongue/throat, difficulty breathing, severe skin reactions (Stevens–Johnson syndrome, toxic epidermal necrolysis), persistent or bloody diarrhea, yellowing of the skin or eyes (jaundice), dark urine, severe abdominal pain, or unusual bruising/bleeding.
• If any side effects persist, worsen, or you notice any other unexpected symptoms, stop the medication and contact your healthcare provider promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature specified on the outer packaging (exact storage temperature is not available in the provided information; follow pack instructions).

Specifications:

• Product type: Prescription systemic antibiotic medicine.
• Active ingredients: Amoxicillin + clavulanic acid (beta-lactam antibiotic plus beta-lactamase inhibitor).
• Strength: 625 mg per film-coated tablet (amoxicillin 500 mg + clavulanic acid 125 mg; exact salt forms and detailed composition not fully specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.)).
• Form: Film-coated tablet for oral administration.
• Pack size: 12 film-coated tablets per pack.
• Intended users: Adults and adolescents as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.